SAFETY OF DOMPERIDONE IN METOCLOPRAMIDE-INDUCED PARKINSONISM

被引：6

作者：

GRIMES, JD

MAGNER, PO

机构：

来源：

ARCHIVES OF NEUROLOGY | 1984年 / 41卷 / 04期

关键词：

D O I：

10.1001/archneur.1984.04050160025009

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：363 / 364

页数：2

相关论文

共 5 条

[1] METOCLOPRAMIDE-INDUCED PARKINSONISM [J].

BUCHHOLZ, D ;

KARIYA, S .

ARCHIVES OF NEUROLOGY, 1983, 40 (08) :528-529

[2]

GRIMES JD, 1982, CAN MED ASSOC J, V126, P23

[3] METOCLOPRAMIDE-INDUCED PARKINSONISM - CLINICAL CHARACTERISTICS OF 10 CASES [J].

INDO, T ;

ANDO, K .

ARCHIVES OF NEUROLOGY, 1982, 39 (08) :494-496

[4] DOMPERIDONE, A SPECIFIC INVITRO DOPAMINE ANTAGONIST, DEVOID OF INVIVO CENTRAL DOPAMINERGIC ACTIVITY [J].

LADURON, PM ;

LEYSEN, JE .

BIOCHEMICAL PHARMACOLOGY, 1979, 28 (14) :2161-2165

[5] BROMOCRIPTINE AND DOMPERIDONE IN THE TREATMENT OF PARKINSON DISEASE [J].

QUINN, N ;

ILLAS, A ;

LHERMITTE, F ;

AGID, Y .

NEUROLOGY, 1981, 31 (06) :662-667